NCT06030843
- Conditions
- Cardio-Renal Syndrome, Cardiovascular Diseases, Empagliflozin in Cardiorenal Syndrome Type 1, +9 more
- Locations
-
- Faculty of Medicine, Chulalongkorn University Bangkok, Pathumwan, Thailand
Clinical trial condition
Empagliflozin in Cardiorenal Syndrome Type 1
Explore clinical trials studying Empagliflozin in Cardiorenal Syndrome Type 1. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study